United States

Orion Oyj (ORNBV.HE)

ORNBV.HE on Helsinki Stock Exchange

11:29am EST
Change (% chg)

€0.35 (+0.88%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ORNBV.HE


Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical... (more)


Beta: 0.57
Market Cap(Mil.): €5,638.65
Shares Outstanding(Mil.): 141.26
Dividend: 1.30
Yield (%): 3.25


  ORNBV.HE Industry Sector
P/E (TTM): 23.34 29.74 30.35
EPS (TTM): 1.71 -- --
ROI: 31.02 15.90 15.27
ROE: 44.04 17.00 16.60

BRIEF-Government Of Singapore buys 5.0 pct stake in Orion

* Says Government Of Singapore has acquired 302,186 shares of the company, increasing its stake in the cpmpany up to 5.0 percent from 0 percent

Nov 28 2016

BRIEF-Orion to divest food business into new subsidiary for system transformation

* Says it will divest its food business into a new subsidiary, named Orion Corp

Nov 22 2016

BRIEF-Finland's Orion Q3 EBIT EUR 92.0 million, above expectations

* Q3 sales 258.6 million euros ($281.64 million) versus 249 million euros seen in Reuters poll

Oct 25 2016

BRIEF-Lydian International receiveS $35 mln from Orion Mine Finance and Resource Capital

* Together with gross proceeds from first deposit, full amount of $60 million under stream agreement has now been advanced to Lydian

Oct 03 2016

BRIEF-Orion Oyj and Menarini Group enter into collaboration agreement

* Says the company and Menarini Group collaborate on budesonide-formoterol Easyhaler combination product for asthma and COPD

Sep 02 2016

BRIEF-ORION to merge with wholly owned subsidiary SPORTSTOTO ONLINE

* Says it will merge with a wholly owned subsidiary, SPORTSTOTO ONLINE Co.,Ltd, which is engaged in information and internet service business, to improve operating efficiency and create synergy

Aug 22 2016

BRIEF-Orion Q2 EBIT beats expectations at EUR 83.5 million

* Q2 EBIT 83.5 million euros ($92.4 million) (Reuters poll 74.4 million euros)

Jul 19 2016

BRIEF-Orion Corporation and Asahi Kasei enters into global strategic collaboration

* Says that it has entered into a global strategi collaboration agreement with Japanese Asahi Kasei Pharma for the discovery, development and commercialisation of assets in pain management

Jun 22 2016

BRIEF-Orion completes share buyback

* Bought total of 500,000 own B shares at average price of about 33.5319 euros per share

Jun 16 2016

BRIEF-Orion upgrades full-year outlook for 2016

* Now sees 2016 operating profit without potential capital gains is estimated to exceed 270 million euros (operating profit was 267 million euros in 2015

Jun 15 2016

Earnings vs. Estimates